In conclusion, this study of Chinese normal BMI patients with T2DM and visceral adiposity revealed that improvement in 2hPBG, insulin sensitivity, pancreatic β-cell function, and SAT were only observed following exenatide therapy. This evidence concerns the gene INS and type 2 diabetes mellitus.